1. Home
  2. MOBX vs BNGO Comparison

MOBX vs BNGO Comparison

Compare MOBX & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobix Labs Inc.

MOBX

Mobix Labs Inc.

HOLD

Current Price

$0.27

Market Cap

22.0M

Sector

N/A

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.56

Market Cap

24.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOBX
BNGO
Founded
2020
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.0M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MOBX
BNGO
Price
$0.27
$1.56
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
1.2M
169.0K
Earning Date
02-17-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,984,000.00
$28,720,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$24.56
P/E Ratio
N/A
N/A
Revenue Growth
180.13
N/A
52 Week Low
$0.26
$1.45
52 Week High
$1.80
$22.80

Technical Indicators

Market Signals
Indicator
MOBX
BNGO
Relative Strength Index (RSI) 26.29 45.88
Support Level $0.26 $1.47
Resistance Level $0.38 $1.63
Average True Range (ATR) 0.05 0.06
MACD -0.01 0.00
Stochastic Oscillator 4.24 40.91

Price Performance

Historical Comparison
MOBX
BNGO

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: